These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36548755)

  • 1. Combining mKate2-Kv1.3 Channel and Atto488-Hongotoxin for the Studies of Peptide Pore Blockers on Living Eukaryotic Cells.
    Orlov NA; Ignatova AA; Kryukova EV; Yakimov SA; Kirpichnikov MP; Nekrasova OV; Feofanov AV
    Toxins (Basel); 2022 Dec; 14(12):. PubMed ID: 36548755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of the Kv1.1 Channel with Peptide Pore Blockers: A Fluorescent Analysis on Mammalian Cells.
    Orlov NA; Kryukova EV; Efremenko AV; Yakimov SA; Toporova VA; Kirpichnikov MP; Nekrasova OV; Feofanov AV
    Membranes (Basel); 2023 Jul; 13(7):. PubMed ID: 37505011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-Terminal Tagging with GFP Enhances Selectivity of Agitoxin 2 to Kv1.3-Channel Binding Site.
    Nekrasova OV; Primak AL; Ignatova AA; Novoseletsky VN; Geras'kina OV; Kudryashova KS; Yakimov SA; Kirpichnikov MP; Arseniev AS; Feofanov AV
    Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33339256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complexes of Peptide Blockers with Kv1.6 Pore Domain: Molecular Modeling and Studies with KcsA-Kv1.6 Channel.
    Nekrasova OV; Volyntseva AD; Kudryashova KS; Novoseletsky VN; Lyapina EA; Illarionova AV; Yakimov SA; Korolkova YV; Shaitan KV; Kirpichnikov MP; Feofanov AV
    J Neuroimmune Pharmacol; 2017 Jun; 12(2):260-276. PubMed ID: 27640211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KcsA-Kv1.x chimeras with complete ligand-binding sites provide improved predictivity for screening selective Kv1.x blockers.
    Szekér P; Bodó T; Klima K; Csóti Á; Hanh NN; Murányi J; Hajdara A; Szántó TG; Panyi G; Megyeri M; Péterfi Z; Farkas S; Gyöngyösi N; Hornyák P
    J Biol Chem; 2024 Apr; 300(4):107155. PubMed ID: 38479597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering-specific pharmacological binding sites for peptidyl inhibitors of potassium channels into KcsA.
    Legros C; Schulze C; Garcia ML; Bougis PE; Martin-Eauclaire MF; Pongs O
    Biochemistry; 2002 Dec; 41(51):15369-75. PubMed ID: 12484776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AgTx2-GFP, Fluorescent Blocker Targeting Pharmacologically Important K
    Primak AL; Orlov NA; Peigneur S; Tytgat J; Ignatova AA; Denisova KR; Yakimov SA; Kirpichnikov MP; Nekrasova OV; Feofanov AV
    Toxins (Basel); 2023 Mar; 15(3):. PubMed ID: 36977120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescent system based on bacterial expression of hybrid KcsA channels designed for Kv1.3 ligand screening and study.
    Kudryashova KS; Nekrasova OV; Kuzmenkov AI; Vassilevski AA; Ignatova AA; Korolkova YV; Grishin EV; Kirpichnikov MP; Feofanov AV
    Anal Bioanal Chem; 2013 Mar; 405(7):2379-89. PubMed ID: 23307127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GFP-Margatoxin, a Genetically Encoded Fluorescent Ligand to Probe Affinity of Kv1.3 Channel Blockers.
    Denisova KR; Orlov NA; Yakimov SA; Kryukova EA; Dolgikh DA; Kirpichnikov MP; Feofanov AV; Nekrasova OV
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of the Inhibitory Peptides ShK and HmK with the Voltage-Gated Potassium Channel K
    Sanches K; Prypoten V; Chandy KG; Chalmers DK; Norton RS
    J Chem Inf Model; 2023 May; 63(10):3043-3053. PubMed ID: 37143234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Terminally extended analogues of the K⁺ channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel Kv1.3.
    Chang SC; Huq R; Chhabra S; Beeton C; Pennington MW; Smith BJ; Norton RS
    FEBS J; 2015 Jun; 282(12):2247-59. PubMed ID: 25864722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide blockers of K
    Chandy KG; Norton RS
    Curr Opin Chem Biol; 2017 Jun; 38():97-107. PubMed ID: 28412597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of agitoxin2, charybdotoxin, and iberiotoxin with potassium channels: selectivity between voltage-gated and Maxi-K channels.
    Gao YD; Garcia ML
    Proteins; 2003 Aug; 52(2):146-54. PubMed ID: 12833539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potassium channel block by a tripartite complex of two cationophilic ligands and a potassium ion.
    Zimin PI; Garic B; Bodendiek SB; Mahieux C; Wulff H; Zhorov BS
    Mol Pharmacol; 2010 Oct; 78(4):588-99. PubMed ID: 20601455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial pore blocker acts specifically on voltage-gated potassium channel isoform K
    Gigolaev AM; Lushpa VA; Pinheiro-Junior EL; Tabakmakher VM; Peigneur S; Ignatova AA; Feofanov AV; Efremov RG; Mineev KS; Tytgat J; Vassilevski AA
    J Biol Chem; 2022 Nov; 298(11):102467. PubMed ID: 36087839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Fluorescent Peptide Toxin for Selective Visualization of the Voltage-Gated Potassium Channel K
    Wai DCC; Naseem MU; Mocsár G; Babu Reddiar S; Pan Y; Csoti A; Hajdu P; Nowell C; Nicolazzo JA; Panyi G; Norton RS
    Bioconjug Chem; 2022 Nov; 33(11):2197-2212. PubMed ID: 36330854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atto488-Agitoxin 2-A Fluorescent Ligand with Increased Selectivity for Kv1.3 Channel Binding Site.
    Denisova KR; Orlov NA; Yakimov SA; Kirpichnikov MP; Feofanov AV; Nekrasova OV
    Bioengineering (Basel); 2022 Jul; 9(7):. PubMed ID: 35877346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate, a small molecular scaffold targeting Kv1.3 channel extracellular pore region.
    Xie Z; Zhao Y; Yang W; Li W; Wu Y; Chen Z
    Biochem Biophys Res Commun; 2020 Nov; 532(2):265-270. PubMed ID: 32863001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antibody targeting the E314 peptide of human Kv1.3 pore region serves as a novel, potent and specific channel blocker.
    Yang XF; Yang Y; Lian YT; Wang ZH; Li XW; Cheng LX; Liu JP; Wang YF; Gao X; Liao YH; Wang M; Zeng QT; Liu K
    PLoS One; 2012; 7(4):e36379. PubMed ID: 22558454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anuroctoxin, a new scorpion toxin of the alpha-KTx 6 subfamily, is highly selective for Kv1.3 over IKCa1 ion channels of human T lymphocytes.
    Bagdány M; Batista CV; Valdez-Cruz NA; Somodi S; Rodriguez de la Vega RC; Licea AF; Varga Z; Gáspár R; Possani LD; Panyi G
    Mol Pharmacol; 2005 Apr; 67(4):1034-44. PubMed ID: 15615696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.